Improved survival in osteosarcoma patients with atypical low vascularization. - Wikidata - awgldk - TriplyDB

Improved survival in osteosarcoma patients with atypical low vascularization.

Improved survival in osteosarcoma patients with atypical low vascularization.

http://www.wikidata.org/entity/Q35231406

about

CD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines.Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma Prediction of optimal gene functions for osteosarcoma using network-based- guilt by association method based on gene oncology and microarray profile MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.

P2860

Q35506606-29977D43-5566-4B22-BE32-EA4D5DA5478E Q35958404-253CC4C3-5274-49B1-9F1E-5215EFF6992D Q36022718-8DBFACAF-706E-42CE-B9AA-49B962534388 Q36262912-788610E4-742D-4AF1-8E58-CC070EABC98E Q38434316-5D31FB0B-F086-48B0-9E7E-F5BE357DD940 Q47193877-5B825365-65E7-41FD-BB03-18B3CA6981A1

P2860

Improved survival in osteosarcoma patients with atypical low vascularization.

http://www.wikidata.org/entity/Q35231406

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Improved survival in osteosarcoma patients with atypical low vascularization.

@ast

Improved survival in osteosarcoma patients with atypical low vascularization.

@en

type

label

Improved survival in osteosarcoma patients with atypical low vascularization.

@ast

Improved survival in osteosarcoma patients with atypical low vascularization.

@en

prefLabel

Improved survival in osteosarcoma patients with atypical low vascularization.

@ast

Improved survival in osteosarcoma patients with atypical low vascularization.

@en

P1433

Q35231406-68EF47EC-33FD-4005-B26D-528B6D6A1611

P1476

Q35231406-E9EE9248-B175-4427-9F73-E015D1827BB0

P2093

Q35231406-22B9B263-6BEE-4B74-9845-8E01C3C73353

Q35231406-252CB587-2505-4BB9-8523-AE297997BA25

Q35231406-311E6DB6-A334-4719-8C1D-C2A229F28DB3

Q35231406-36EDF7BA-6CB2-4DC3-BEE4-1DBD2C994506

Q35231406-487CB7DF-0E15-442F-8FF8-9C1D9DD860B7

Q35231406-506E9DF9-76D7-4C92-A3E5-6F492DFF16A9

Q35231406-657A7693-A2DD-4094-916F-1DA2A7036616

Q35231406-6CE3B399-6FD0-4E3C-9ABF-9F9472B2834C

Q35231406-75F22845-A328-4FFD-A5B8-44314C096076

Q35231406-817FF927-72F7-41E1-BF7D-5CB5322A3D89

P2860

Q35231406-1F822D10-47F9-471B-BF19-D15269255D68

Q35231406-371661FA-2FAA-4B93-96AD-BC70C9A661BD

Q35231406-4015E37E-37B2-40B7-9801-7D6E0013176C

Q35231406-6BCC89B6-9FE1-471B-9DC0-13CE369B01B7

Q35231406-81C59CED-D28C-48C5-BFE7-D203DF33DB0E

Q35231406-8DC91C07-D71D-4741-9FDE-1075BD41A2BD

Q35231406-A3655A76-E652-413C-8D8D-D36B019A26C1

Q35231406-AE3C5B67-B273-48BB-82BC-1F4EA7B4B5C7

Q35231406-B286D234-A96D-4BF3-9160-155802B0088F

Q35231406-B3C4D0A2-4D64-4CE0-8078-1FF5911F8461

P2888

Q35231406-DD7D6921-B50C-4D7E-B854-799B518D80BC

P304

Q35231406-9F9A8446-B893-4B98-8056-A665D010AD00

P31

Q35231406-E393BE4D-DBE1-4FA0-B66B-D26BE59B156A

P356

Q35231406-15977826-0702-47AC-8C5C-4A88EA876A7F

P433

Q35231406-79BE6F44-5540-4ADA-B0F1-8CCBF7D12E8C

P478

Q35231406-0833B90A-E6A1-434A-A174-39A504DD1660

P577

Q35231406-DC4EB7CF-C496-4B9C-8938-F9877044E6D7

P5875

Q35231406-93BAEBCA-46CF-4CE1-BEF7-97F6C9A7EF93

P6179

Q35231406-CD1D241F-6D1D-4C9A-8509-33F832BA05EA

P698

Q35231406-D4165AF6-71BC-47FA-A708-1A8FA4F5B67D

P356

S10434-014-4001-2

P1433

Annals of Surgical Oncology

P1476

Improved survival in osteosarcoma patients with atypical low vascularization.

@en

P2093

Antonio Llombart Bosch

http://www.w3.org/2001/XMLSchema#string

Benedikt Fritzsching

http://www.w3.org/2001/XMLSchema#string

Burkhard Lehner

http://www.w3.org/2001/XMLSchema#string

Isidro Machado

http://www.w3.org/2001/XMLSchema#string

Joerg Fellenberg

http://www.w3.org/2001/XMLSchema#string

Johannes Poeschl

http://www.w3.org/2001/XMLSchema#string

Linda Moskovszky

http://www.w3.org/2001/XMLSchema#string

Michael Bohlmann

http://www.w3.org/2001/XMLSchema#string

Miklos Szendrõi

http://www.w3.org/2001/XMLSchema#string

Peter Ruef

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.

Outcome of patients with osteosarcoma over 40 years of age: is angiogenesis a marker of survival?

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.

Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.

Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma

A review of clinical and molecular prognostic factors in osteosarcoma.

The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.

A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.

P2888

s10434-014-4001-2

P304

489-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-014-4001-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265054684

http://www.w3.org/2001/XMLSchema#string

P6179

1030658074

http://www.w3.org/2001/XMLSchema#string

P698

25155396

http://www.w3.org/2001/XMLSchema#string